News

D-Wave Quantum’s QBTS third-quarter 2025 results show an improvement in the company’s operations. The company reported gross profit of $2.7 million, up 156% year over year. Meanwhile, GAAP gross

Nu Holdings’ NU strongest differentiator at this stage of its growth cycle is its rising revenue durability, the company’s ability to convert a massive customer base into recurring, multi-product

Friday, December 5, 2025Pre-market futures had been up across the board, but have fallen off the table in recent minutes. We’re now 25 minutes before the opening bell, and we still have yet to see

Gap Inc. GAP delivered an impressive third-quarter fiscal 2025 performance, highlighted by broad-based strength across its key brands. Company-wide comps rose 5%, the highest in more than four

The Bank of New York Mellon Corporation’s BK shares touched a new 52-week high of $114.43 in Thursday’s trading session. Over the past six months, BK stock has gained 26.2%, outperforming the indust

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 5: 

Credo Technology Group Holding Ltd CRDO: This connectivity solutions provider has a

AST SpaceMobile, Inc. ASTS shares were up 18.3% yesterday, driven by the euphoria related to its upcoming BlueBird satellite launch on Dec. 15. The uptrend was also buoyed by OpenAI CEO Sam Altman’s

The market’s rally has been fueled by AI for quite some time now, with the “Magnificent Seven” significantly outperforming the S&P 500 and accounting for much of the gains. This outperformance is

KBR, Inc. KBR has expanded its U.K. presence after securing a U.S. Navy contract to provide Foreign Military Sales support for the Naval Air Systems Command’s (NAVAIR) F/A-18 and EA-18G Program

For investors seeking momentum, State Street SPDR S&P Biotech ETF XBI is probably on the radar. The fund just hit a 52-week high and has risen 85.43% from its 52-week low price of $66.66/share.

But

Amicus Therapeutics FOLD has been making meaningful progress with its lead product, Galafold (migalastat), which has been driving the majority of the company’s revenues. The drug has remained a key

Denali Therapeutics Inc. DNLI has announced a funding agreement with Royalty Pharma plc RPRX for $275 million. The stock gained 5.84% following the announcement.

The deal centers on future net sales

From a technical perspective, ATN International, Inc. (ATNI) is looking like an interesting pick, as it just reached a key level of support. ATNI's 50-day simple moving average crossed above its

Benitec Biopharma Limited (BNTC) closed the last trading session at $13.18, gaining 9.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Shares of Theravance Biopharma (TBPH) have gained 25.8% over the past four weeks to close the last trading session at $18.7, but there could still be a solid upside left in the stock if short-term

Shares of Atlassian (TEAM) have gained 0.3% over the past four weeks to close the last trading session at $156.54, but there could still be a solid upside left in the stock if short-term price

Profound Medical (PROF) closed the last trading session at $6.75, gaining 15.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

After reaching an important support level, SiBone (SIBN) could be a good stock pick from a technical perspective. SIBN recently experienced a "golden cross" event, which saw its 50-day simple moving

Sprinklr (CXM) closed the last trading session at $7.9, gaining 5.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Transportadora De Gas Sa Ord B (TGS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TGS's 50-day simple moving average

Archer Aviation Inc. (ACHR) closed the last trading session at $8.95, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of Mineralys Therapeutics, Inc. (MLYS) have gained 5.1% over the past four weeks to close the last trading session at $38.91, but there could still be a solid upside left in the stock if

Shares of Pagaya Technologies Ltd. (PGY) have gained 6.4% over the past four weeks to close the last trading session at $24.88, but there could still be a solid upside left in the stock if

If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, try the growth at a reasonable price or GARP strategy.The strategy helps investors gain

The Campbell's Company CPB is likely to register a decrease in the top and bottom lines when it reports first-quarter fiscal 2026 earnings on Dec. 9. The Zacks Consensus Estimate for revenues is